Search Results - "Pomplun, M"

Refine Results
  1. 1

    The effects of task difficulty on visual search strategy in virtual 3D displays by Pomplun, Marc, Garaas, Tyler W, Carrasco, Marisa

    Published in Journal of vision (Charlottesville, Va.) (28-08-2013)
    “…Analyzing the factors that determine our choice of visual search strategy may shed light on visual behavior in everyday situations. Previous results suggest…”
    Get full text
    Journal Article
  2. 2

    A model of top-down attentional control during visual search in complex scenes by Hwang, Alex D, Higgins, Emily C, Pomplun, Marc

    Published in Journal of vision (Charlottesville, Va.) (27-05-2009)
    “…Recently, there has been great interest among vision researchers in developing computational models that predict the distribution of saccadic endpoints in…”
    Get full text
    Journal Article
  3. 3

    Phase I Study of Continuous-Infusion l-S,R-Buthionine Sulfoximine With Intravenous Melphalan by Bailey, Howard H., Ripple, Greg, Tutsch, Kendra D., Arzoomanian, Rhoda Z., Alberti, Dona, Feierabend, Chriss, Mahvi, David, Schink, Julian, Pomplun, Marcia, Mulcahy, R. Timothy, Wilding, George

    “…Background: Increased intracellular glutathione has long been associated with tumor cell resistance to various cytotoxic agents. An inhibitor of glutathione…”
    Get full text
    Journal Article
  4. 4

    Phase I clinical trial of perillyl alcohol administered daily by RIPPLE, G. H, GOULD, M. N, STEWART, J. A, TUTSCH, K. D, ARZOOMANIAN, R. Z, ALBERTI, D, FEIERABEND, C, POMPLUN, M, WILDING, G, BAILEY, H. H

    Published in Clinical cancer research (01-05-1998)
    “…Perillyl alcohol (POH; NSC-641066), a naturally occurring monoterpene, has shown antitumor and preventive activity in preclinical studies in rodent models…”
    Get full text
    Journal Article
  5. 5

    Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione by Bailey, H H, Mulcahy, R T, Tutsch, K D, Arzoomanian, R Z, Alberti, D, Tombes, M B, Wilding, G, Pomplun, M, Spriggs, D R

    Published in Journal of clinical oncology (01-01-1994)
    “…A phase I dose-escalation trial of intravenous (IV) L-buthionine-SR-sulfoximine (BSO) with melphalan (L-PAM) was performed to determine the toxicity and…”
    Get more information
    Journal Article
  6. 6

    A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer by Love, R R, Jacoby, R, Newton, M A, Tutsch, K D, Simon, K, Pomplun, M, Verma, A K

    “…DFMO is an irreversible inhibitor of ornithine decarboxylase (ODC), the key enzyme in mammalian polyamine biosynthesis. The goal of this study was to determine…”
    Get full text
    Journal Article
  7. 7

    Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine by Carbone, P P, Douglas, J A, Larson, P O, Verma, A K, Blair, I A, Pomplun, M, Tutsch, K D

    “…A two-step Phase I study of piroxicam (PXM) and a-difluoromethylornithine (DFMO) alone and in combination was initiated to assess toxicity and the impact of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Low-Dose Difluoromethylornithine and Polyamine Levels in Human Prostate Tissue by Messing, Edward M., Love, Richard R., Tutsch, Kendra D., Verma, Ajit K., Douglas, Jeffrey, Pomplun, Marcia, Simsiman, Ruby, Wilding, George

    “…Difluoromethylornithine is a non-competitive inhibitor of ornithine decarboxylase, which catalyzes the rate-limiting step in polyamine synthesis. Futher…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20